Kyma Neuro appears positioned as a developer-first non-invasive BCI platform, combining low-cost sensing hardware with APIs, models, and application tooling. Its current status is very early, with public materials centered on a planned 2026 developer-kit release rather than validated applications or regulated clinical use.